Project: KMM has been assisting the management of Closed Loop Therapies Ltd. in the creation of a strategic cooperation with Prof. Jordaens, head of Electrophysiology at the Thorax Centre of Erasmus MC. Furthermore, KMM helped to establish a Dutch company in order to acquire pre-seed funding for CLT.
About CLT: CLT aims to develop and commercialise a novel therapeutic system, consisting of an arrhythmia-detecting drug pump combined with a unique drug, for automatic and immediate treatment of emerging atrial fibrillation (AF). Market size is estimated at 2.5-3 billion Euro, annually.
See also: Website of Closed Loop Therapies: www.cltmedical.com